Mobin Wan

1.2k total citations
15 papers, 362 citations indexed

About

Mobin Wan is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Mobin Wan has authored 15 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Mobin Wan's work include Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). Mobin Wan is often cited by papers focused on Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). Mobin Wan collaborates with scholars based in China, United States and Switzerland. Mobin Wan's co-authors include Chengzhong Li, Xue-Song Liang, Ying Zhou, Li Chen, Xinxin Zhang, Demin Yu, Qian Zhang, Xia-qiu Zhou, Shanming Wu and Lungen Lu and has published in prestigious journals such as Journal of Hepatology, World Journal of Gastroenterology and Liver International.

In The Last Decade

Mobin Wan

14 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mobin Wan China 8 282 256 55 42 38 15 362
Marzia Margotti Italy 10 317 1.1× 323 1.3× 49 0.9× 34 0.8× 80 2.1× 19 449
Huanwei Zheng China 8 214 0.8× 204 0.8× 49 0.9× 28 0.7× 30 0.8× 31 299
Yunjie Dan China 11 185 0.7× 183 0.7× 41 0.7× 45 1.1× 60 1.6× 18 339
Pamela Valva Argentina 12 250 0.9× 225 0.9× 49 0.9× 74 1.8× 33 0.9× 24 399
Yong Kwang Park South Korea 11 209 0.7× 150 0.6× 48 0.9× 94 2.2× 36 0.9× 16 319
Helena M. Daniels United Kingdom 8 209 0.7× 201 0.8× 66 1.2× 48 1.1× 29 0.8× 11 344
Yongbin Zeng China 11 222 0.8× 147 0.6× 31 0.6× 121 2.9× 52 1.4× 31 330
Yinong Ye China 9 130 0.5× 118 0.5× 54 1.0× 26 0.6× 16 0.4× 16 219
Zhandong Li China 11 205 0.7× 181 0.7× 18 0.3× 37 0.9× 38 1.0× 15 317

Countries citing papers authored by Mobin Wan

Since Specialization
Citations

This map shows the geographic impact of Mobin Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mobin Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mobin Wan more than expected).

Fields of papers citing papers by Mobin Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mobin Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mobin Wan. The network helps show where Mobin Wan may publish in the future.

Co-authorship network of co-authors of Mobin Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Mobin Wan. A scholar is included among the top collaborators of Mobin Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mobin Wan. Mobin Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wan, Mobin, et al.. (2019). An expert consensus on the adjustment of treatment strategies in patients with chronic hepatitis B treated with non-firstline nucleos(t)ide analogues.. 39(6). 529–532. 1 indexed citations
2.
Sun, Jian, Hong Ma, Qing Xie, et al.. (2016). Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study. Journal of Hepatology. 65(4). 674–682. 36 indexed citations
3.
Hou, Jinlin, Guangfeng Shi, Mobin Wan, et al.. (2015). Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B. Advances in Therapy. 32(8). 727–741. 18 indexed citations
4.
Jia, Jidong, Jinlin Hou, Deming Tan, et al.. (2013). Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients. Hepatology International. 8(1). 72–82. 13 indexed citations
5.
Liang, Xue-Song, Chengzhong Li, Ying Zhou, & Mobin Wan. (2012). Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection. BMC Gastroenterology. 12(1). 43–43. 58 indexed citations
6.
Gane, Edward, Yuming Wang, Yun‐Fan Liaw, et al.. (2011). Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B. Liver International. 31(5). 676–684. 37 indexed citations
7.
Li, Chen, Shaojun Xing, Xuezhang Duan, Mobin Wan, & Huifen Wang. (2011). [The study on frequency distribution of regulatory T cells and its functional markers in peripheral blood of chronic hepatitis B].. PubMed. 25(1). 33–5. 1 indexed citations
8.
Chen, Li & Mobin Wan. (2010). Comparison and interpretation of chronic hepatitis B guidelines on the anti-virus treatment.. 30(12). 1085–1087. 1 indexed citations
10.
Chen, Li, Qian Zhang, Demin Yu, Mobin Wan, & Xinxin Zhang. (2009). Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy. Journal of Hepatology. 50(5). 895–905. 55 indexed citations
11.
Jia, Jidong, Jinlin Hou, Dao-zhen Xu, et al.. (2007). [The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52].. PubMed. 15(5). 342–5. 3 indexed citations
12.
Zhao, Hong, et al.. (2006). [A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].. PubMed. 14(5). 323–6. 3 indexed citations
13.
Lu, Lungen, Minde Zeng, Yimin Mao, et al.. (2003). Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trial. World Journal of Gastroenterology. 9(11). 2480–2480. 69 indexed citations
14.
Lu, Lungen, Minde Zeng, Mobin Wan, et al.. (2003). Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters. World Journal of Gastroenterology. 9(11). 2574–2574. 66 indexed citations
15.
Wan, Mobin, et al.. (2003). [Construction of X-gene defect HBV expression plasmid and cells transfection study].. PubMed. 11(8). 508–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026